Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04772547
Other study ID # VIGAB-STAT IIa
Secondary ID IRB202003076OCR4
Status Completed
Phase Phase 2
First received
Last updated
Start date September 22, 2021
Est. completion date December 31, 2023

Study information

Verified date February 2023
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot trial of a single loading dose of vigabatrin in post-anoxic status epilepticus.


Description:

This pilot trial aims to demonstrate the feasibility of enteral administration of a single load of vigabatrin within targeted 48 hours of post-anoxic status epilepticus onset in unconscious survivors of cardiac arrest undergoing targeted temperature management. The load of VGB is in addition to the load of a commonly used intravenous second-line therapy given at the discretion of the treating neurologist. Serial blood tests will be obtained, including vigabatrin levels, taurine levels, neuron specific enolase, light chain neurofilament, and glial fibrillary acidic protein. In survivors that regain consciousness and survive to follow up, 6 months visual field perimetry will be obtained.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - age = 18 years - non-traumatic cardiac arrest (regardless of non-perfusing rhythm, etiology, or location of arrest) in whom the decision to treat unequivocal electrographic status epilepticus (as defined by the American Clinical Neurophysiology Society: having generalized spike/sharp-wave discharges = 3Hz or any evolving pattern reaching > 4Hz, lasting = 10 minutes, or comprising > 50% of any hour of recording) has been made - requiring anesthetic infusion for any reason - have reliable arterial access for frequent blood sampling - established enteral access within 48h of post-anoxic status epilepticus onset. Exclusion Criteria: - prior history of generalized epilepsy - history of gastrointestinal surgery within the last 21 days - pregnancy - status epilepticus onset preceding initiation of electroencephalography monitoring

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Vigabatrin Only Product
enteral medication administration, serial blood draws, and outcome assessment

Locations

Country Name City State
United States University of Florida Gainesville Florida

Sponsors (4)

Lead Sponsor Collaborator
University of Florida American Heart Association, Thomas Jefferson University, Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vigabatrin levels Blood levels of vigabatrin using high-performance liquid chromatography. Detectable levels of vigabatrin in 80% of subjects by 3 hours and 100% of subjects by 12 hours will be considered the threshold for adequate absorption. up to day 7
See also
  Status Clinical Trial Phase
Completed NCT03504709 - REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
Withdrawn NCT00593164 - Clinical Study of the LRS ThermoSuitâ„¢ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate Phase 2
Completed NCT02486211 - Amantadine to Speed Awakening After Cardiac Arrest Phase 2
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Not yet recruiting NCT04584463 - Factors Associated With CPC 1-2 in 110 Patients Admitted in French ICU for a Myocardial Infarction Complicated by an OHCA.
Recruiting NCT02338284 - Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure N/A
Completed NCT00577954 - Multimodal Resonance Imaging for Outcome Prediction on Coma Patients N/A
Recruiting NCT05861323 - Feasibility of the Comfort Measures Only Time Out (CMOT) N/A
Not yet recruiting NCT06036732 - A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
Active, not recruiting NCT03826407 - Development of a Point of Care System for Automated Coma Prognosis
Completed NCT03616054 - International Observational Study on Airway Management in Critically Ill Patients
Completed NCT00573014 - Cervical Spine Clearance in Obtunded Trauma Patients N/A
Completed NCT01973829 - The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN) N/A
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT05321459 - Predictive Outcome in Comatose Patients
Not yet recruiting NCT04623294 - Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
Recruiting NCT04876222 - Direct or Subacute Coronary Angiography in Patients With Out of Hospital Cardiac Arrest Without Coma. N/A
Not yet recruiting NCT06321146 - Evaluation of EEG Power Spectrum in Patients With Traumatic Coma
Completed NCT03926494 - Carbon Monoxide-induced Coma: Prognostic Factors
Completed NCT00880204 - Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training N/A